Home
Conditions
Bone Marrow Diseases

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,003 public trials 530 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Recruiting

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

NCT03128034

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +34 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

NCT03670966

Conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, +37 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

NCT04726241

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, +23 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

View all 183 locations

View Trial Details

Recruiting

CHIP/CCUS Natural History Protocol

NCT04102423

Conditions: Bone Marrow Diseases, Clonal Cytopenia of Undetermined Significance, Clonal Hematopoiesis of Indeterminate Potential, +4 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

NCT03113643

Conditions: Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, +16 more
Locations: City of Hope Duarte, California, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Familial Investigations of Childhood Cancer Predisposition

NCT03050268

Conditions: AML, Abnormalities, Multiple, Acute Leukemia, +206 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

NCT04024761

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +12 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

NCT06138587

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

NCT05876312

Conditions: Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations: Nucleus Network Brisbane Brisbane, Queensland, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

Royal Melbourne Hospital Parkville, Victoria, Australia

Richmond Pharmacology Ltd London, United Kingdom

View Trial Details

Recruiting

A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial

NCT06786234

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations: Hôpital de la Milétrie, CHU Poitiers, New Aquitaine, France

CHU Brest Brest, France

Institut Paoli-Calmettes Marseille, France

CHU Nantes Nantes, France

View all 14 locations

View Trial Details

Bone Marrow Diseases

Bone Marrow Diseases trial results

Related conditions